Loading clinical trials...
Loading clinical trials...
A Double-blind, Randomized, Placebo-controlled Study to Assess the Effect of 336 Days Exposure of Paractin® on Pain & Disease Progression in Patients Suffering From Osteoarthritis of Knee Joint.
Conditions
Interventions
Andrographis paniculata [150 mg]
Microcrystalline Cellulose (MCC)
Locations
5
India
Ayush Nursing Home
Mumbai, Maharashtra, India
New Healthcare Nursing Home
Thane, Maharashtra, India
Jaipur National University Institute for Medical Sciences and Research Center
Jaipur, Rajasthan, India
Asopa Hospital
Jaipur, Rajasthan, India
Shubham Sudbhawana Super Specialty Hospital
Varanasi, Uttar Pradesh, India
Start Date
March 13, 2021
Primary Completion Date
February 20, 2024
Completion Date
February 20, 2024
Last Updated
May 31, 2025
NCT07036003
NCT07302724
NCT07544693
NCT06758388
NCT07078149
NCT06870656
Lead Sponsor
Vedic Lifesciences Pvt. Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions